Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Veerababu Nagati
Observed names:
Nagati, Veerababu,
VEERABABU NAGATI,
Veera Babu Nagati
Institution:
The University of Texas Rio Grande Valley
Observed institutions:
University of Pittsburgh,
The University of Texas Rio Grande Valley,
University of Hyderabad,
Osmania University
ORCID:
0000-0001-8584-9393
Observed ORCID:
0000-0001-8584-9393
OpenAlex ID:
A5068560944
Green synthesis and characterization of Carica papaya leaf extract coated silver nanoparticles through X-ray diffraction, electron microscopy and evaluation of bactericidal properties
2015
·
Rajkiran Reddy Banala
, Veera Babu Nagati
, et al.
·
Saudi Journal of Biological Sciences
·
233
Green synthesis of silver nanoparticles using leaf extract of medicinally potent plant Saraca indica: a novel study
2015
·
Shyam Perugu
, Veerababu Nagati
, et al.
·
Applied Nanoscience
·
79
PDF
Neuroblastoma: Emerging trends in pathogenesis, diagnosis, and therapeutic targets
2023
·
Santharam S. Katta
, Veerababu Nagati
, et al.
·
Journal of Controlled Release
·
37
Stability of therapeutic nano-drugs during storage and transportation as well as after ingestion in the human body
2022
·
Veerababu Nagati
, Swathi Tenugu
, et al.
·
Elsevier eBooks
·
31
Antibacterial activity of silver nanoparticles synthesized using Amaranthus viridis twig extract
2014
·
Rama Koyyati
, Veera Babu Nagati
, et al.
·
International Journal of Research in Pharmaceutical Sciences
·
29
Hypoxia-Inducible Factor-2α Promotes Liver Fibrosis by Inducing Hepatocellular Death
2024
·
Raja Gopal Reddy Mooli
, Dhanunjay Mukhi
, et al.
·
International Journal of Molecular Sciences
·
15
Non-enzymatic glycation and diabetic kidney disease
2024
·
Anil K. Pasupulati
, Veerababu Nagati
, et al.
·
Vitamins and hormones
·
10
Disulfide engineering on temporin‐ SH f: Stabilizing the bioactive conformation of an ultra‐short antimicrobial peptide
2019
·
Ashwini Dolle
, Veera Babu Nagati
, et al.
·
Chemical Biology & Drug Design
·
10
PDF
Transcription factor YBX1 orchestrates drug resistance and tumor progression in HCC
2025
·
Dennis Kwabiah
, Veerababu Nagati
, et al.
·
Drug Discovery Today
·
8
PDF
Forskolin-loaded human serum albumin nanoparticles and its biological importance
2019
·
Veerababu Nagati
, Sailaja Nakkka
, et al.
·
Journal of Biomolecular Structure and Dynamics
·
7
Exploration of binding studies of β-oxalyldiamino propionic acid (β-ODAP), a non-protein amino acid with human serum albumin-biophysical and computational approach
2018
·
Veerababu Nagati
, Monika Kallubai
, et al.
·
Journal of Biomolecular Structure and Dynamics
·
5
Computational Repurposing and Experimental Validation of YBX1 Inhibitors in Hepatocellular Carcinoma
2026
·
Omar Karkoutly
, Veerababu Nagati
, et al.
·
Biomedicines
·
4
PDF
Epigenetically active chromatin in neonatal iWAT reveals GABPα as a potential regulator of beige adipogenesis
2024
·
Raja Gopal Reddy Mooli
, Bokai Zhu
, et al.
·
Frontiers in Endocrinology
·
4
PDF
Extracellular Synthesis of Mono and Bimetallic Nanocomposites from Novel Strains of Rhodopseudomonas palustris and Evaluation of Their Biomedical Applications
2022
·
Rama Koyyati
, Karunakar Rao Kudle
, et al.
·
Macromolecular Symposia
·
4
Metabolic reprogramming and drug resistance in hepatocellular carcinoma: The emerging role of SREBP2-driven cholesterol metabolism
2026
·
Veerababu Nagati
, Swathi Tenugu
, et al.
·
Drug Discovery Today
·
1
Abstract 386: Targeting the YBX1-SREBP2 axis to overcome drug resistance in hepatocellular carcinoma.
2026
·
Veerababu Nagati
, Yamile Abuchard Anaya
, et al.
·
Cancer Research
·
1
Abstract 1785: Aspects of the YBX1-dependent mechanism of drug resistance in hepatocellular carcinoma
2026
·
Yamile Abuchard Anaya
, Ana Ayala Pazzi
, et al.
·
Cancer Research
·
1
Safety assessment of rat embryonic fraction for in vivo regenerative therapy
2024
·
Sivarama Prasad Darsi
, Somorita Baishya
, et al.
·
Biology Open
·
1
PDF
YBX1 Orchestrates SREBP2-Driven Cholesterol Metabolism to Confer Drug Resistance in Hepatocellular Carcinoma
2026
·
Nagati, Veerababu
, Salazar, Miguel
, et al.
·
ScholarWorks @ UTRGV (The University of Texas Rio Grande Valley)
PDF
YBX1 Promotes Drug Resistance in Hepatocellular Carcinoma and Serves as a Potential Therapeutic Target
2026
·
Manish Tripathi
, VEERABABU NAGATI
, et al.
·
Research Square
PDF
Abstract 2236: Evaluation of novel medicinal compounds for therapeutic efficacy against liver cancer.
2026
·
Aarya M. Tripathi
, Veerababu Nagati
, et al.
·
Cancer Research
Abstract 3074: Sorafenib resistance and cholesterol metabolism in hepatocellular carcinoma
2025
·
Veerababu Nagati
, Dennis Kwabiah
, et al.
·
Cancer Research
Abstract 5555: Potential pathways underlying sorafenib resistance in hepatocellular carcinoma
2025
·
Yamile Abuchard Anaya
, Ana Ayala Pazzi
, et al.
·
Cancer Research
Show more works
View as search
Works count:
25
Citation count:
480
H-index:
8
I10-index:
8
Year
Topic
Type